THOMAS LUCAS: Open Payments
NPI 1477746998 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 18 payments from 9 companies in 2025. Trend: 2023 $1,124 · 2024 $1,203 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $78 |
| ABBVIE INC. | 3 | $66 |
| PFIZER INC. | 3 | $53 |
| Novo Nordisk Inc | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: FREESTYLE LIBRE 3, NURTEC ODT, VRAYLAR, NEXLETOL, QULIPTA, Wegovy, Auvelity, KRYSTEXXA.
Industry payments across SC — which companies pay providers there.
